Viatris, Inc. is a global healthcare company, which engages in the provision of healthcare and pharmaceutical products. The company is headquartered in Canonsburg, Pennsylvania. The firm's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment reflects its operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America, and the Middle East, as well as the Company’s Antiretroviral medicines (ARV) franchise. Its pipeline and research and development capabilities include expertise in formulation, device development, toxicology, analytical, clinical, bioanalytical, medical affairs, product safety and risk management across a range of therapeutic areas. The company produces oral solid doses, injectables, and products with complex dosage forms.
Mr. Scott Smith es el Chief Executive Officer de Viatris Inc, se unió a la empresa desde 2022.
¿Qué tal es el rendimiento del precio de la acción VTRS?
El precio actual de VTRS es de $13, ha disminuido un 0.34% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Viatris Inc?
Viatris Inc pertenece a la industria Pharmaceuticals y el sector es Health Care
¿Cuál es la capitalización bursátil de Viatris Inc?
La capitalización bursátil actual de Viatris Inc es $14.9B
¿Es Viatris Inc una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 11 analistas han realizado calificaciones de análisis para Viatris Inc, incluyendo 3 fuerte compra, 5 compra, 6 mantener, 2 venta, y 3 fuerte venta